ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 173 filers reported holding ANI PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $14,651,431 | +918.6% | 230,079 | +1005.8% | 0.01% | +600.0% |
| Q1 2024 | $1,438,388 | +17.0% | 20,807 | -6.7% | 0.00% | 0.0% |
| Q4 2023 | $1,229,622 | +130.6% | 22,300 | +125.1% | 0.00% | – |
| Q2 2023 | $533,240 | +79726.3% | 9,906 | -41.1% | 0.00% | – |
| Q1 2023 | $668 | -37.6% | 16,807 | -36.9% | 0.00% | -100.0% |
| Q4 2022 | $1,071 | -99.9% | 26,634 | -48.7% | 0.00% | 0.0% |
| Q3 2022 | $1,667,000 | +50.5% | 51,868 | +38.9% | 0.00% | 0.0% |
| Q2 2022 | $1,108,000 | -52.7% | 37,334 | -55.2% | 0.00% | 0.0% |
| Q1 2022 | $2,341,000 | +909.1% | 83,270 | +1076.8% | 0.00% | – |
| Q3 2021 | $232,000 | -65.5% | 7,076 | -69.4% | 0.00% | – |
| Q4 2020 | $672,000 | -4.7% | 23,152 | +33.8% | 0.00% | -100.0% |
| Q1 2020 | $705,000 | +41.0% | 17,305 | +144.2% | 0.00% | +100.0% |
| Q1 2019 | $500,000 | +2.5% | 7,085 | -34.6% | 0.00% | 0.0% |
| Q4 2018 | $488,000 | -34.0% | 10,831 | -17.2% | 0.00% | 0.0% |
| Q3 2018 | $739,000 | -73.3% | 13,078 | -72.5% | 0.00% | -75.0% |
| Q1 2018 | $2,768,000 | +1218.1% | 47,544 | +1360.2% | 0.00% | – |
| Q4 2017 | $210,000 | -74.7% | 3,256 | -81.6% | 0.00% | -100.0% |
| Q2 2017 | $830,000 | +41.9% | 17,729 | +50.1% | 0.00% | 0.0% |
| Q1 2017 | $585,000 | +9.8% | 11,813 | +23.7% | 0.00% | 0.0% |
| Q2 2016 | $533,000 | -36.7% | 9,546 | -61.9% | 0.00% | -50.0% |
| Q1 2016 | $842,000 | -31.8% | 25,025 | -8.5% | 0.00% | -33.3% |
| Q4 2015 | $1,234,000 | -22.2% | 27,343 | -31.9% | 0.00% | 0.0% |
| Q3 2015 | $1,587,000 | -6.3% | 40,173 | +47.2% | 0.00% | 0.0% |
| Q2 2015 | $1,694,000 | -77.8% | 27,299 | -77.6% | 0.00% | -78.6% |
| Q1 2015 | $7,632,000 | +2125.1% | 122,016 | +1903.9% | 0.01% | +1300.0% |
| Q4 2014 | $343,000 | -35.0% | 6,089 | -67.4% | 0.00% | 0.0% |
| Q3 2014 | $528,000 | -94.5% | 18,670 | -93.3% | 0.00% | -96.3% |
| Q2 2014 | $9,591,000 | -32.9% | 278,490 | -39.0% | 0.03% | -34.1% |
| Q1 2014 | $14,303,000 | – | 456,223 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 509,952 | $37,165,000 | 4.50% |
| Mesirow Financial Investment Management, Inc. | 7,649 | $557,000 | 2.34% |
| Hawk Ridge Capital Management | 154,961 | $11,294,000 | 2.26% |
| Global Alpha Capital Management Ltd. | 147,046 | $10,717,000 | 1.86% |
| 1492 Capital Management LLC | 25,181 | $1,835,000 | 1.79% |
| PERKINS CAPITAL MANAGEMENT INC | 22,783 | $1,660,000 | 1.43% |
| THB ASSET MANAGEMENT | 87,102 | $6,347,000 | 1.18% |
| Consonance Capital Management LP | 142,943 | $10,418,000 | 1.03% |
| Phocas Financial Corp. | 127,200 | $9,270,000 | 0.99% |
| Regent Investment Management LLC | 39,659 | $2,890,000 | 0.95% |